Skip to content
Search AI Powered

Latest Stories

Spearheading the Future of Medical Cannabis in Latin America

Like most of the world, Latin American countries are in dire need of medical cannabis reform.
Like most of the world, Latin American countries are in dire need of medical cannabis reform.

The U.S. wasn't the only country to face challenges with cannabis stigma when the war on pot was first launched in the early 1900s.

Latin America has experienced a similar (if not even more severe) stigma against cannabis for decades, despite the fact that it’s been utilized for healing and wellness for several centuries. However, that’s finally beginning to change – and it’s largely thanks to the efforts of a few medical cannabis companies and advocates making a fearless mark on the region.


Based in Colombia, Khiron is not only working to destigmatize medical cannabis in Latin America and provide plant access to patients in need. Their mission is to entirely reimagine the way healthcare is approached throughout the globe, prioritizing long-term healing and wellness that permanently bids “throwing pills at the problem” goodbye.

Latin America’s War on Weed, and The Resulting Opioid Crisis

Founded in 2017, Khiron came together a couple of years after Colombia announced the nationwide legalization of medical cannabis in 2015. Much like the U.S., Colombia was plagued by the negative effect of the War on Drugs for decades, resulting in a collective view of cannabis as a dangerous and unpredictable drug that should remain outlawed.

But although Khiron was founded on the tails of medical cannabis legalization and has played an integral role in cannabis advocacy throughout Latin America, cannabis isn’t necessarily the central focus of the organization.

“I’m not a cannabis user, so that isn’t necessarily what appealed to me when founding Khiron,” said Alvaro Torres, Khiron Founder and CEO.

“What did appeal to me was this: we come from a country that has been at the forefront of this War on Drugs for many decades, and I found it fascinating that we could take a plant that has been long associated with harm and transform it into something that can really improve lives.”

Torres went on to compare Colombia and Latin America as a whole to the U.S. once again: just as North America demonized cannabis and pushed opioids on the population, resulting in a nationwide crisis of severe, paralyzing addiction, a similar plight is plaguing Latin America.

“We are going through the same issues the U.S. has with opiates. The idea that we can come up with a medication that can be produced in our continent and is much less harmful…it can change the entire social fabric of our country and the way we approach medicine,” Torres said.

“And Latin Americans being able to produce something for ourselves that will help improve our lives was an incredible thought. That’s why Khiron was named Khiron – after the wise centaur in Greek mythology who invented medicine in order to naturally heal. This is a company primarily focused on improving quality of life.”

Bringing Education and Access to Patients in Need

Khiron began by offering medical health centers that treat cannabis patients throughout Colombia, and they’ve since expanded to Brazil with plans to launch a new clinic in the U.K. in the near future. 

Their clinics offer a wide variety of alternatives that allow people to select medicine that optimizes the health of their mind, body, and soul. While they don’t view cannabis as the answer to everything, it’s certainly a very good answer for many issues that opiates are only confounding.

“All the work we’ve done has been at the forefront of changing people’s perceptions on medical cannabis. Today, there’s a major shift in the public’s view on the plant from what I was seeing five years ago,” Torres said.

“People are starting to learn more about medical cannabis. There’s still a bit of resistance from a societal perspective, but you can see that patients and doctors are a lot more open to the plant than ever before.”

A lot of this shift has to do with social media, where cannabis patients have flocked to share their stories.

“When you can hear these success stories from real people instead of paid advertising, it has a profound effect on viewers. But it takes time,” Torres said. 

“When I started the company, even my own family was shocked and somewhat resistant. But the undeniable fact is that so many people are in pain, and we can’t treat all of that with opioids. Perceptions are changing, but we need to broaden that message to governments, financial institutions, and lenders, so that everyone realizes we’re not talking about the devil here.”

Khiron’s medical clinics are doing just that on the frontlines, providing patient access from a safe, beautiful, and approachable location that works to destigmatize cannabis as the bogey man and reintroduce it as a healing and beneficial plant.

The team focuses on customer service above all else, ensuring that everyone who visits a clinic knows they aren’t going to be pressured to consume cannabis. They’re simply going to be educated on opiate alternatives and given a variety of natural medicine options that work for their needs – which may or may not include cannabis.

“Medical cannabis isn’t a fad. It’s here to stay. It will bring a lower cost of healthcare, more jobs, and act as a major disruption to the traditional pharmaceutical industry and how medicine is understood. We’ve learned a lot of lessons from the U.S. markets to help us create better regulations and access for patients,” Torres said.

“But overall, it’s time for medicine to change. You can’t take an old plant that has been doing good for centuries and dismiss it because it was dismissed for all the wrong reasons in the first place. Once we get out of that mentality, we will all be successful.”

Need a little more Bluntness in your life? Subscribe for our newsletter to stay in the loop.

More For You

Erven's Solonje Burnett & Angela Bacon
Erven's Solonje Burnett & Angela Bacon
Photo: Cindy Trinh 2024 | Erven

Erven Founders Solve Cannabis Industry Problems with Tech and Tenacity

"I remember when I realized how broken communication was in cannabis," recalls Solonje Burnett, Erven co-founder. "A California-based edible brand founder shared how dispensary managers across the state were overwhelmed and consistently not responding to her emails."

This pivotal insight via a chance meeting at NCIA conference in San Francisco in December 2021 marked the genesis of Erven, a startup revolutionizing communication and data-sharing in the evolving cannabis industry.

Keep ReadingShow less
How much are you paying for your weed?
How much are you paying for your weed?

FAQ: How Much Is A Gram Of Weed? An Ounce?

If you’re new to buying weed, one of the first things to learn is quantities. That’s because at a certain point, there are greater savings that come with buying higher quantities. 

Additionally, sometimes you find a favorite strain, and it’s only available in certain sizes. 

Keep ReadingShow less
The Airgraft 2 is raising eyebrows during its June 2021 pre-launch.
The Airgraft 2 is raising eyebrows during its June 2021 pre-launch.

Airgraft Brings Major Disruption to World of Cannabis Concentrates

The spread of cannabis legalization is great news, and there is an understandable amount of fear surrounding who will be first to take over the legal industry, and how accessible and affordable the plant will end up being for the average consumer. 

Cannabis vaporizer brand Airgraft is determined to both address this issue and flip the industry on its head with their release of Airgraft 2, offering an insanely affordable membership program unlike anything cannabis has ever seen before. 

Keep ReadingShow less
The list of cannabinoids continues to grow.
The list of cannabinoids continues to grow.
Image by Bob G from Pixabay

Answered: WTF is Delta 9 THC-JD (and is it the strongest cannabinoid)?

Scientists are still discovering more plant-based cannabinoids and endogenous cannabinoids which leaves us to wonder how many more are left undiscovered. 

In 2020 alone, scientists discovered over nine novel plant-based cannabinoids, including THCB, CBDB, THCH, CBCH, THCP, CBDP, CBGM, THCM, CBDM, and THCJD. 

Keep ReadingShow less
Battle over cannabis licenses in NY intensifies; MSO's Seek to Join Veterans Lawsuit
Battle over cannabis licenses in NY intensifies; MSO's Seek to Join Veterans Lawsuit

Battle Over Cannabis Licenses in New York Intensifies; MSOs Seek to Join Veterans Lawsuit

This story has been updated on Friday, August 11, 2023.

The landscape of New York's cannabis industry has been further convoluted by the entrance of powerful Multi-State Operators (MSOs) into the legal fray. The Coalition for Access to Regulated & Safe Cannabis (CARSC), a trade organization backed by prominent MSOs including Acreage Holdings, Curaleaf, Green Thumb Industries, and PharmaCann, has inserted itself into the recently filed lawsuit against the Office of Cannabis Management (OCM) and the Cannabis Control Board (CCB) from four veterans who are claiming the CAURD program is unconstitutional. 

Keep ReadingShow less